NIH-funded research R03 grant

Understanding how herpes simplex virus enters human cells

Official title: The Golgi complex and HSV entry

Funded at Washington State University · NIH-11133068 · Data updated 2026-11-12

This study is looking at how the herpes virus gets into our skin cells, which can cause cold sores and other issues, to help find better ways to treat these infections.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionWashington State University
NIH-funded
Lab location1 site (Pullman, United States)
Project startJuly 5, 2024
Project endMay 31, 2026
Funding year2025
Award (this year)$76,500
NIH project number5R03AI178458-02
Project IDNIH-11133068 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who experience recurrent herpes simplex virus infections, including those with cold sores or genital herpes.

Less likely to help

Patients who do not have herpes simplex virus infections or those with other unrelated viral infections may not benefit from this research.

What this research studies

This research investigates the pathway that the herpes simplex virus (HSV) takes to enter human epithelial cells, which can lead to conditions like cold sores and blindness. The researchers aim to identify the specific vesicular compartments that HSV traverses during its entry, focusing on the role of the Golgi complex in this process. By employing techniques from cell biology, biochemistry, and microscopy, the study seeks to clarify how HSV successfully infects cells, which could inform future treatment strategies. The findings may provide insights into the mechanisms of viral entry and potential therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating HSV infections, potentially reducing the incidence of related diseases.

How similar studies have gone: Previous research has identified pathways for viral entry, but this specific focus on the Golgi complex in HSV entry is relatively novel and has not been extensively tested.

Where this research is happening

  • Washington State University
    Pullman, United States
    Active

Researchers

  • Principal investigator: Nicola, Anthony V — Washington State University
  • Study coordinator: Nicola, Anthony V

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.